Literature DB >> 9883219

Bladder tumours detected on screening: results at 7 years.

M P Mayfield1, P Whelan.   

Abstract

OBJECTIVES: To report the outcome at a minimum follow-up of 7 years of a cohort of tumours that were asymptomatic at presentation and detected in a previous community-based screening programme (with reduced mortality and progression at 3 years of follow-up). PATIENTS AND METHODS: In the original screening, 2356 men aged > or = 60 years had a dipstick test for microscopic haematuria; 474 (20%) had positive results and of these, 317 agreed to further investigation. Twenty-one were found to have bladder tumours; this was reduced to 17 after pathological review. No tumours were muscle-invasive at diagnosis. The outcome of this cohort was evaluated at 7 years of follow-up.
RESULTS: The patients were grouped on the basis of their original histology. In group A, four patients had no tumour on histological review and none progressed in grade or stage. In group B, eight patients reported to have well differentiated superficial tumours (i.e. G1pTa) had no recorded deaths from cancer or progression to muscle-invasive disease. In group C, of nine patients with tumours having a potentially worse prognosis (G1-2, > or = pT1, or carcinoma in situ, three died from bladder cancer, two progressed to muscle-invasive disease (one of whom died from unrelated causes) and two further patients died from unrelated causes.
CONCLUSION: This cohort of patients represents a unique group, in that all had superficial disease at the time of diagnosis. The outcome at 3 years was excellent, but in the subsequent 4 years many patients had progression of their cancer. All patients who developed invasive disease were in group C; as their disease was identified at a superficial stage it may have been amenable to aggressive early management not usually associated with such grade and stage.

Entities:  

Mesh:

Year:  1998        PMID: 9883219     DOI: 10.1046/j.1464-410x.1998.00879.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

Review 1.  Is there a rationale for bladder cancer screening?

Authors:  Robert S Svatek; Yair Lotan
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

Review 2.  Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.

Authors:  Farnoosh Nik-Ahd; A Lenore Ackerman; Jennifer Anger
Journal:  Curr Urol Rep       Date:  2018-09-13       Impact factor: 3.092

3.  Screening for bladder cancer: the best opportunity to reduce mortality.

Authors:  Yves Fradet
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 4.  Screening for bladder cancer: a perspective.

Authors:  Yair Lotan; Robert S Svatek; Núria Malats
Journal:  World J Urol       Date:  2007-11-21       Impact factor: 4.226

5.  Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants.

Authors:  Maria C Mir; Andrew J Stephenson; Robert L Grubb; Amanda Black; Adam S Kibel; Grant Izmirlian
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

6.  Rationale for an early detection program for bladder cancer.

Authors:  Makarand V Khochikar
Journal:  Indian J Urol       Date:  2011-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.